Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy

被引:4
|
作者
Zhou, Yaofeng [1 ]
Li, Qianying [1 ]
Wu, Yuhao [1 ]
Zhang, Wan [2 ]
Ding, Lu [3 ]
Ji, Chenlin [4 ]
Li, Ping [1 ]
Chen, Tingtao [5 ]
Feng, Lili [6 ]
Tang, Ben Zhong [7 ]
Huang, Xiaolin [1 ]
机构
[1] Nanchang Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Resources, Nanchang 330047, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanchang 330006, Peoples R China
[3] Nanchang Univ, Affiliated Hosp 1, Jiangxi Hypertens Res Inst, Dept Cardiol, Nanchang 330006, Peoples R China
[4] Westlake Univ, Sch Engn, Hangzhou 310030, Peoples R China
[5] Nanchang Univ, Natl Engn Res Ctr Bioengn Drugs & Technol, Inst Translat Med, Nanchang 330036, Peoples R China
[6] Harbin Engn Univ, Coll Mat Sci & Chem Engn, Key Lab Superlight Mat & Surface Technol, Minist Educ, Harbin 150001, Peoples R China
[7] Chinese Univ Hong Kong Shenzhen CUHK Shenzhen, Sch Sci & Engn, Shenzhen 518172, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
engineered bacteria; multimodal cancer therapy; nanobiohybrid; nanomedicine; synergistic enhancement; PHOTOTHERMAL THERAPY; SYSTEMIC DELIVERY; RNA-INTERFERENCE; IMMUNE-RESPONSES; COATED BACTERIA; TUMOR; NANOPARTICLES; STRATEGY; SURFACE; CHEMOTHERAPY;
D O I
10.1002/adma.202313953
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Engineered bacteria are widely used in cancer treatment because live facultative/obligate anaerobes can selectively proliferate at tumor sites and reach hypoxic regions, thereby causing nutritional competition, enhancing immune responses, and producing anticancer microbial agents in situ to suppress tumor growth. Despite the unique advantages of bacteria-based cancer biotherapy, the insufficient treatment efficiency limits its application in the complete ablation of malignant tumors. The combination of nanomedicine and engineered bacteria has attracted increasing attention owing to their striking synergistic effects in cancer treatment. Engineered bacteria that function as natural vehicles can effectively deliver nanomedicines to tumor sites. Moreover, bacteria provide an opportunity to enhance nanomedicines by modulating the TME and producing substrates to support nanomedicine-mediated anticancer reactions. Nanomedicine exhibits excellent optical, magnetic, acoustic, and catalytic properties, and plays an important role in promoting bacteria-mediated biotherapies. The synergistic anticancer effects of engineered bacteria and nanomedicines in cancer therapy are comprehensively summarized in this review. Attention is paid not only to the fabrication of nanobiohybrid composites, but also to the interpromotion mechanism between engineered bacteria and nanomedicine in cancer therapy. Additionally, recent advances in engineered bacteria-synergized multimodal cancer therapies are highlighted. Herein, the first systematic and comprehensive review of the development of engineered bacteria in cancer, is provided; and the unique advantages of combining bacteria as anticancer agents with nanomedicines are discussed. This review focuses on the role of bacteria in cancer therapy, integration strategy of bacteria and nanotherapeutic drugs, synergistic mechanism of bacteria and nanomedicines, and bacteria-synergized multimodal cancer therapy. image
引用
收藏
页数:42
相关论文
共 50 条
  • [21] A Metal-Polyphenol-Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic Therapy
    Ren, Zhigang
    Sun, Shichao
    Sun, Ranran
    Cui, Guangying
    Hong, Liangjie
    Rao, Benchen
    Li, Ang
    Yu, Zujiang
    Kan, Quancheng
    Mao, Zhengwei
    ADVANCED MATERIALS, 2020, 32 (06)
  • [22] Cancer Therapy Through Nanomedicine The National Cancer Institute's plan to defeat cancer through engineered design
    Hinkal, George W.
    Farrell, Dorothy
    Hook, Sara S.
    Panaro, Nicholas J.
    Ptak, Krzysztof
    Grodzinski, Piotr
    IEEE NANOTECHNOLOGY MAGAZINE, 2011, 5 (02) : 5 - 11
  • [23] Stimuli-responsive nanomedicine for synergistic leukemia therapy
    Kemp, Jessica
    Hong, Cheol
    Edson, Julius
    Kwon, Young
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [24] Genetically engineered eukaryocyte-bacteria hybrid membrane-camouflaged nanoemulsion for three-pronged synergistic cancer therapy
    Zhang, Yifan
    Liao, Yunyan
    Bai, Fang
    Xing, Shaojun
    Wang, Meng
    Dang, Zechun
    Lin, Jing
    Huang, Peng
    NANO TODAY, 2024, 54
  • [25] Nanomedicine in Cancer Targeting and Therapy
    Palama, Ilaria Elena
    Leporatti, Stefano
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (08):
  • [26] Engineered nanoparticles for synergistic antimicrobial therapy
    Gupta, Akash
    Saleh, Neveen
    Li, Xiaoning
    Bigdeli, Arafeh
    Saha, Krishnendu
    Landis, Ryan
    Mahmoudi, Morteza
    Rotello, Vincent
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [27] Nanomedicine for Combination Therapy of Cancer
    He, Chunbai
    Chan, Christina
    Weichselbaum, Ralph R.
    Fleming, Gini F.
    Yamada, S. Diane
    Lin, Wenbin
    EBIOMEDICINE, 2015, 2 (05): : 366 - +
  • [28] Epigenetics in cancer therapy and nanomedicine
    Annalisa Roberti
    Adolfo F. Valdes
    Ramón Torrecillas
    Mario F. Fraga
    Agustin F. Fernandez
    Clinical Epigenetics, 2019, 11
  • [29] Immunomodulating Nanomedicine for Cancer Therapy
    Liu, Zhigang
    Jiang, Wen
    Nam, Jutaek
    Moon, James J.
    Kim, Betty Y. S.
    NANO LETTERS, 2018, 18 (11) : 6655 - 6659
  • [30] Epigenetics in cancer therapy and nanomedicine
    Roberti, Annalisa
    Valdes, Adolfo F.
    Torrecillas, Ramon
    Fraga, Mario F.
    Fernandez, Agustin F.
    CLINICAL EPIGENETICS, 2019, 11 (1)